NDI Notifications For CBD ‘Excluded’ On Arrival But US FDA Still Explains Where Safety Evidence Fails

CFSAN Office of Dietary Supplement Programs tells Charlotte’s Web and Irwin Naturals that not providing sufficient evidence of a reasonable assumption of safety for an NDI's intended use wasn’t the only reason each notification was rejected.

The US Food and Drug Administration went to the trouble when rejecting two firms’ new dietary ingredient notifications for cannabidiol of explaining that the firms didn’t provide sufficient safety information after first stating that CBD is unlawful for use as a dietary ingredient anyway.

Both of the letters the Center for Food Safety and Applied Nutrition’s Office of Dietary Supplement Programs submitted on 23...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Cannabis/CBD

More from Ingredients & Safety